In this week’s episode of “Podnosis,” we’re diving deep into the current landscape of clinical trials in the U.S. 

Various stakeholders face a complicated web of challenges in the system. Many patients, particularly from marginalized groups, struggle to find and get into trials. Meanwhile, with the acceleration of decentralized trial sites throughout the COVID-19 pandemic, some research programs are struggling to keep up financially. Between specialized technology, staffing and compliance measures, there’s a lot that goes into ensuring success. And unfortunately, these hardships are enough to turn some physicians away from clinical research. 

Alexander Saint-Amand is the co-founder and CEO of Topography Health, a company focused on helping medical practices and health systems conduct trials at scale. In this episode, he chats with Fierce Healthcare’s Anastassia Gliadkovskaya about what he sees as lacking in the industry today and what it will take to build out trust and capacity for the future.

To learn more about the topics in this episode:  

• HLTH24: Atropos Health unveils chat-based AI co-pilot for real-world evidence
• Dandelion Health launches AI marketplace for model validation, use in clinical trials
• Walgreens eyes 'tremendous growth' for clinical trials as part of transformation strategy